In T2DM, not only increased adipose tissue mass but other metabolic disturbances, including hyperinsulinemia, hyperglycemia, and dyslipidemia, alter adipose tissue function and lead to increased production and circulating levels of PAI-1 [25]. The gene discussed is SERPINE1; the disease is metabolic syndrome.